{
}
UBS maintains a Neutral rating on Allianz's stock, keeping the target price at €300 following the Group's investor day. The firm does not expect significant changes in EPS or capital distribution under Allianz's new three-year plan, highlighting the need for a reassessment for a more favorable valuation.
UBS maintains a neutral stance on Allianz stock following the recent CMD. BOURSORAMA, acting solely as a distribution channel, emphasizes that the analysis is provided for informational purposes and does not reflect its views. The institution adheres to strict conflict of interest management policies to ensure objectivity in its investment recommendations.
UBS has maintained a neutral rating on Allianz SE, a leading global insurance group also involved in banking. The company's revenue is primarily derived from life and health insurance (47.9%) and non-life insurance (47.1%), with asset management contributing 5%. As of the end of 2023, Allianz manages EUR 2,224 billion in assets.
UBS has maintained a 'Neutral' rating for Allianz SE with a price target of 300 euros following a recent capital market event. Analyst Will Hardcastle deemed the profit targets credible, noting they are largely reflected in the current share price, with no significant changes expected in earnings consensus estimates. As of the latest trading, Allianz shares are priced at approximately 301.90 euros, reflecting a 1.27% increase.
UBS has maintained a "Neutral" rating on Allianz shares with a target price of 300 euros, as the insurer's three-year targets align with expectations. Allianz shares fell 0.4% to EUR 297.40, indicating a slight upside potential. The company is set to release its Q4 2024 results on February 28, 2025.
Allianz shares face limited upside potential, with analysts expressing reduced optimism despite a consistent dividend policy. Currently priced at EUR 310.88, the stock is only 4% below the average target price, and seasonal trends show modest gains ahead. Chart analysis indicates potential risks, including a negative divergence in the relative strength index, suggesting caution for investors.
UBS AG has maintained a "Neutral" rating on Allianz, setting a target price of 300 euros, as the insurer's three-year targets align with expectations. As of 10:21 a.m. in XETRA trading, Allianz shares fell 0.4% to EUR 297.40, reflecting a 29.4% increase since the start of 2024, with 312,137 shares traded today. Quarterly results for Q4 2024 are anticipated on February 28, 2025.
UBS has maintained a neutral recommendation for Allianz SE, a leading global insurance group also involved in banking. The company's revenue is primarily derived from life and health insurance (47.9%) and non-life insurance (47.1%), with asset management contributing 5%. As of the end of 2023, Allianz manages EUR 2,224 billion in assets.
UBS AG has maintained a "Neutral" rating on Allianz shares with a target price of 300 euros, following an analysis that aligns with the insurer's three-year targets. As of the latest trading, Allianz shares fell by 1.8% to EUR 293.30, indicating a potential upside of 2.28%. The company's Q4 2024 balance sheet is anticipated on February 28, 2025.
UBS has maintained a "Neutral" rating on Allianz with a target price of 300 euros. Analyst Will Hardcastle noted that the insurer's three-year targets align closely with expectations, indicating minimal changes to consensus forecasts.
Allianz SE
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
UBS Maintains Neutral Rating on Allianz Following Investor Day Insights
12:40 11.12.2024
UBS Maintains Neutral Rating on Allianz Stock After Recent Analysis
12:40 11.12.2024
Allianz SE Maintains Strong Position in Global Insurance and Banking Markets
10:38 11.12.2024
UBS Maintains Neutral Rating for Allianz SE with 300 Euro Target
09:52 11.12.2024
UBS Maintains Neutral Rating on Allianz with Target Price of 300 Euros
12:09 10.12.2024
Allianz Shares Face Limited Upside Amid Analyst Caution and Seasonal Weakness
10:44 10.12.2024
UBS Maintains Neutral Rating on Allianz with Target Price of 300 Euros
10:37 10.12.2024
Allianz SE Maintains Strong Position in Global Insurance and Banking Markets
10:34 10.12.2024
UBS Maintains Neutral Rating on Allianz Shares with Target Price of 300 Euros
10:27 10.12.2024
UBS Maintains Neutral Rating on Allianz with Target Price of 300 Euros
09:38 10.12.2024
Trending
Subcategory
Stock Market Updates
Corporate News
Industry Trends
Global Trade Developments
Global Financial Events
Finance Mergers & Acquisitions
Banking Regulations
Retail and Consumer Goods
Startups & Entrepreneurship
Central Bank Actions
Industry Mergers & Acquisitions
Inflation and Monetary Impact
Government Economic Policies
Market Analysis and Predictions
CEO Changes
Domestic Politics
Government Policies
Workplace Trends
GDP Growth & Recession Forecasts
Financial Scams and Security
Countries:
Companies:
JPMorgan Chase & Co.
Tesla, Inc.
Apple Inc.
Barclays PLC
Deutsche Bank Money Market PP
The Goldman Sachs Group, Inc.
Banco Santander, S.A.
Credit Suisse Strategic Income I
Berkshire Hathaway Inc.
Lloyds Banking Group plc
SpaceXCoin USD
Morgan Stanley
Amazon.com, Inc.
UBS Group AG
Bank of America Corporation
Wells Fargo & Company
BNP Paribas SA
NVIDIA Corporation
Bank Frick AG
UniCredit S.p.A.
Currencies:
United States Dollar
Euro
British Pound Sterling
Japanese Yen
Swiss Franc
Indian Rupee
Chinese Yuan
South Korean Won
Canadian Dollar
Vietnamese Đồng
Australian Dollar
Thai Baht
Singapore Dollar
Indonesian Rupiah
New Taiwan Dollar
Mexican Peso
Russian Ruble
Hong Kong Dollar
Offshore Chinese Yuan
New Zealand Dollar
People:
Donald Trump
Elon Musk
Warren Buffett
JD Vance
Sergio Ermotti
Mark Haefele
Robin Leopold
Troy L Rohrbaugh
Jennifer Piepszak
Olivier Calvet
Karoline Leavitt
Ursula von der Leyen
Scott Bessent
Stacey Friedman
George Saravelos
Susan P. Crawford
Francois Xavier Bouvignies
Joseph Spak
Stefan Rauti
Jeff Bezos